- Home
- CLAR vs IKT Comparison
CLAR vs IKT Comparison
Compare CLAR & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLAR
- IKT
- Stock Information
- Founded
- CLAR 1957
- IKT 2008
- Country
- CLAR United States
- IKT United States
- Employees
- CLAR N/A
- IKT N/A
- Industry
- CLAR Recreational Games/Products/Toys
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- CLAR Consumer Discretionary
- IKT Health Care
- Exchange
- CLAR Nasdaq
- IKT Nasdaq
- Market Cap
- CLAR 174.9M
- IKT 159.2M
- IPO Year
- CLAR N/A
- IKT 2020
- Fundamental
- Price
- CLAR $4.57
- IKT $3.42
- Analyst Decision
- CLAR Buy
- IKT Strong Buy
- Analyst Count
- CLAR 4
- IKT 2
- Target Price
- CLAR $6.50
- IKT $6.50
- AVG Volume (30 Days)
- CLAR 239.8K
- IKT 471.4K
- Earning Date
- CLAR 11-07-2024
- IKT 11-14-2024
- Dividend Yield
- CLAR 2.19%
- IKT N/A
- EPS Growth
- CLAR N/A
- IKT N/A
- EPS
- CLAR 0.13
- IKT N/A
- Revenue
- CLAR $269,413,000.00
- IKT $1.00
- Revenue This Year
- CLAR N/A
- IKT N/A
- Revenue Next Year
- CLAR $9.30
- IKT N/A
- P/E Ratio
- CLAR $36.11
- IKT N/A
- Revenue Growth
- CLAR 48.98
- IKT N/A
- 52 Week Low
- CLAR $3.89
- IKT $1.12
- 52 Week High
- CLAR $7.55
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- CLAR 43.68
- IKT 52.41
- Support Level
- CLAR $4.89
- IKT $3.12
- Resistance Level
- CLAR $5.03
- IKT $4.20
- Average True Range (ATR)
- CLAR 0.23
- IKT 0.42
- MACD
- CLAR -0.06
- IKT -0.00
- Stochastic Oscillator
- CLAR 12.12
- IKT 30.67
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.